Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

352 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness And Safety Of Ustekinumab Intensification At 90 Mg Every Four Weeks In Crohn's Disease: A Multicenter Study.
Fumery M, Peyrin-Biroulet L, Nancey S, Altwegg R, Gilletta C, Veyrard P, Bouguen G, Viennot S, Poullenot F, Filippi J, Buisson A, Bozon A, Brazier F, Pouillon L, Flourie B, Boivineau L, Siproudhis L, Laharie D, Roblin X, Diouf M, Treton X. Fumery M, et al. Among authors: roblin x. J Crohns Colitis. 2020 Sep 8:jjaa177. doi: 10.1093/ecco-jcc/jjaa177. Online ahead of print. J Crohns Colitis. 2020. PMID: 32898232 Free article.
Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis.
Daniel F, Loriot MA, Seksik P, Cosnes J, Gornet JM, Lémann M, Fein F, Vernier-Massouille G, De Vos M, Boureille A, Treton X, Flourié B, Roblin X, Louis E, Zerbib F, Beaune P, Marteau P. Daniel F, et al. Among authors: roblin x. Inflamm Bowel Dis. 2007 Jan;13(1):19-23. doi: 10.1002/ibd.20046. Inflamm Bowel Dis. 2007. PMID: 17206635 Free article.
A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.
Roblin X, Peyrin-Biroulet L, Phelip JM, Nancey S, Flourie B. Roblin X, et al. Am J Gastroenterol. 2008 Dec;103(12):3115-22. doi: 10.1111/j.1572-0241.2008.01743.x. Am J Gastroenterol. 2008. Retraction in: Am J Gastroenterol. 2009 Mar;104(3):801. doi: 10.1038/ajg.2009.101 PMID: 19086961 Retracted. Clinical Trial.
"Comment on a retraction": author response.
Roblin X, Peyrin-Biroulet L, Phélip JM, Nancey S, Flourié B. Roblin X, et al. Am J Gastroenterol. 2009 Jul;104(7):1864-5. doi: 10.1038/ajg.2009.351. Am J Gastroenterol. 2009. PMID: 19574985 No abstract available.
Infliximab for refractory ulcerative proctitis.
Bouguen G, Roblin X, Bourreille A, Feier L, Filippi J, Nancey S, Bretagne JF, Flourié B, Hébuterne X, Bigard MA, Siproudhis L, Peyrin-Biroulet L. Bouguen G, et al. Among authors: roblin x. Aliment Pharmacol Ther. 2010 Jun;31(11):1178-85. doi: 10.1111/j.1365-2036.2010.04293.x. Epub 2010 Mar 8. Aliment Pharmacol Ther. 2010. PMID: 20222911 Free article.
352 results